From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision Medicine

Cancer drug discovery is an inefficient process, with more than 90% of newly-discovered therapies failing to gain regulatory approval. Patient-derived models of cancer offer a promising new approach to identify new treatments; however, for rare cancers, such as sarcomas, access to patient samples is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Rao, Sneha R., Somarelli, Jason A., Altunel, Erdem, Selmic, Laura E., Byrum, Mark, Sheth, Maya U., Cheng, Serene, Ware, Kathryn E., Kim, So Young, Prinz, Joseph A., Devos, Nicolas, Corcoran, David L., Moseley, Arthur, Soderblom, Erik, Hsu, S. David, Eward, William C.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026496/
https://ncbi.nlm.nih.gov/pubmed/32117764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00117
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados